Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
09/30/20228:37AMGlobeNewswire Inc.OpGen Announces $3.38 Million Registered Direct OfferingNASDAQ:OPGNOpGen Inc
09/20/20224:39PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
09/20/20227:30AMGlobeNewswire Inc.OpGen Subsidiary Curetis and FIND Sign R&D Collaboration Agreement for Unyvero A30 RQ PlatformNASDAQ:OPGNOpGen Inc
09/06/20227:30AMGlobeNewswire Inc.OpGen Announces Participation at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:OPGNOpGen Inc
08/31/20227:30AMGlobeNewswire Inc.Nasdaq Grants OpGen 180-Day Extension to Meet Minimum Bid Price RequirementNASDAQ:OPGNOpGen Inc
08/25/20227:30AMGlobeNewswire Inc.OpGen Launches Ares Sequencing Services in the U.S. from its Rockville, Maryland LaboratoryNASDAQ:OPGNOpGen Inc
08/12/20224:47PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
08/11/20225:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
08/11/20224:15PMGlobeNewswire Inc.OpGen Reports Second Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
07/28/20227:30AMGlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Second Quarter 2022 on August 11th at 4:30 p.m. Eastern TimeNASDAQ:OPGNOpGen Inc
07/26/20227:30AMGlobeNewswire Inc.OpGen Subsidiary Ares Genetics GmbH Enters into Collaboration Agreement with the Belgian National Reference Centre for Invasive S. pneumoniae at UZ LeuvenNASDAQ:OPGNOpGen Inc
07/08/20224:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
07/08/20227:30AMGlobeNewswire Inc.OpGen Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2022 and Provides Business UpdateNASDAQ:OPGNOpGen Inc
06/24/20224:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
06/22/20228:00AMGlobeNewswire Inc.OpGen Announces Publication of Results of Unyvero Hospitalized Pneumonia (HPN) Panel for Detection of Bacterial Respiratory Tract Pathogens from Serial Specimens Collected from Hospitalized COVID-19 PatientsNASDAQ:OPGNOpGen Inc
06/22/20227:30AMGlobeNewswire Inc.OpGen Announces 1,000th Patient Sample Enrolled in Clinical Trial for Unyvero Urinary Tract Infection PanelNASDAQ:OPGNOpGen Inc
06/11/20225:08AMTipRanksH.C. Wainwright Thinks OpGenā€™s Stock is Going to RecoverNASDAQ:OPGNOpGen Inc
06/10/20224:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
06/10/20224:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
06/10/20224:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
06/09/20227:30AMGlobeNewswire Inc.OpGen Subsidiary Curetis and Leader Life Sciences Enter into Unyvero Distribution Partnership for U.A.E. and QatarNASDAQ:OPGNOpGen Inc
06/03/20224:56PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPGNOpGen Inc
06/03/20224:51PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPGNOpGen Inc
06/01/202212:03PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPGNOpGen Inc
05/27/20226:15AMTipRanksH.C. Wainwright Thinks OpGenā€™s Stock is Going to RecoverNASDAQ:OPGNOpGen Inc
05/26/20227:30AMGlobeNewswire Inc.OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory MedicineNASDAQ:OPGNOpGen Inc
05/24/20224:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
05/13/20224:55PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
05/13/20226:26AMTipRanksH.C. Wainwright Thinks OpGenā€™s Stock is Going to RecoverNASDAQ:OPGNOpGen Inc
05/12/20224:45PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN